HealthQuill Pharma
Moderna’s mRNA vaccine candidate in combination with Merck Co.’s, therapy, Keytruda, showed greater survival rates and efficacy in patients with skin cancer or melanoma.
Pharma

Moderna and Merck’s personalised mRNA vaccine clears Phase 3 in melanoma

HQ Team August 20, 2026: Moderna’s stock more than doubled, surging as much as 177% intraday to $174.38 on Aug. 19, 2026, after.

Read More
An epidemic caused by the Bundibugyo virus will continue to spread in the central African country of Congo at an “unprecedented speed” until every transmission chain is found and broken, Dr Tedros Adhanom Ghebreyesus, the Director-General of the World Health Organization, said.
Drugs Health Pharma

World still ‘playing catch-up’ with Ebola virus epidemic in Congo: WHO chief

HQ Team August 19, 2026: An epidemic caused by the Bundibugyo virus will continue to spread in the central African country of Congo.

Read More
AstraZeneca has stopped an end-phase trial for its experimental lung cancer drug, volrustomig, after data showed the combination therapy failed to outperform standard treatments for advanced non-small cell lung cancer.
Drugs Health Pharma

AstraZeneca ends late-stage trial of drug to treat non-small cell cancer

HQ Team August 17, 2026: AstraZeneca has stopped an end-phase trial for its experimental lung cancer drug, volrustomig, after data showed the combination.

Read More
Eli Lilly will invest an additional $450 million to expand its manufacturing capacity at Research Triangle Park facility in North Carolina.
Pharma

The weight-loss drug race just got crowded

Jay Shankar July 21, 2026: Global obesity medicine sales hit $66 billion in 2025 and are on track to reach $92 billion this.

Read More
GSK Plc., a British global pharmaceutical company, announced the FDA had approved an oral drug to treat anaemia arising from chronic kidney disease in patients who have been on dialysis for four months.
Drugs Pharma

FDA expands approval of kidney cancer drug to earlier-stage patients

HQ Team June 16, 2026: The US Food and Drug Administration (FDA) has expanded approval of belzutifan, a first-in-class kidney cancer drug, to.

Read More
Bharat Biotech, an Indian maker of vaccines for infectious diseases, has rolled out the world's first nasal Covid-19 drops as a booster dose, according to a company statement.
Drugs Pharma

AI-designed universal vaccine against coronavirus passes human trial

HQ Team June 9, 2026: Researchers at the University of Cambridge and UK biotech firm DIOSynVax have designed a vaccine targeting the entire.

Read More
The death toll in the Ebola outbreak in the Democratic Republic of Congo (DRC) and Uganda climbed to 130 as the WHO stated the situation as “deeply disturbing.”
Drugs Health Pharma

Ebola outbreak deaths at 130, WHO says situation ‘deeply concerning’

The death toll in the Ebola outbreak in the Democratic Republic of Congo (DRC) and Uganda climbed to 130 as the WHO stated.

Read More
The WHO has declared an Ebola outbreak in the Democratic Republic of Congo (DRC) and Uganda as a public health emergency following the death of 80 people linked to the disease and stated the risk was high that it could spread to neighbouring nations
Drugs Health Pharma

WHO declares Ebola outbreak in Congo, Uganda, as a public health emergency

The WHO has declared an Ebola outbreak in the Democratic Republic of Congo (DRC) and Uganda as a public health emergency following the.

Read More
Cholera cases fell 17% month-on-month to 16,198 in 16 countries across three regions of the World Health Organization in March, according to a statement from the global health agency on April 30.
Climate Health Pharma

Global cholera cases decline 17% in March: Global health agency 

Cholera cases fell 17% month-on-month to 16,198 in 16 countries across three regions of the World Health Organization in March, according to a.

Read More
US FDA clears Abbott Laboratories' new software to clear heart blockages.
Health Medical Pharma

Abbott gets FDA nod for software to help doctors open blocked arteries

May 3, 2026: The US Food and Drug Administration has cleared Abbott Laboratories’ new artificial-intelligence-powered software for coronary imaging, enabling doctors to have.

Read More